Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 521 shares, a growth of 330.6% from the October 15th total of 121 shares. Based on an average trading volume of 3,288 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.0% of the company’s shares are sold short.
Mosaic ImmunoEngineering Stock Performance
Shares of OTCMKTS:CPMV opened at $0.06 on Thursday. The company has a market cap of $434,400.00, a PE ratio of -0.67 and a beta of -0.87. Mosaic ImmunoEngineering has a 52 week low of $0.05 and a 52 week high of $0.75. The firm has a 50 day simple moving average of $0.13 and a 200 day simple moving average of $0.45.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.02) EPS for the quarter.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering, Inc. is a biotechnology company focused on developing immunotherapies designed to stimulate the body’s immune system to fight cancer. Its work has centered on therapeutic approaches intended to improve immune recognition and response against tumors. The company’s development activities have included DNA-based immunotherapy technology, including approaches designed to deliver immune-stimulating genetic material directly to tumor tissue. These therapies are intended to generate localized immune activation while supporting broader systemic anti-tumor responses.
See Also
- Five stocks we like better than Mosaic ImmunoEngineering
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
